Rising the incidence of cancer worldwide, the demand for customized medication and tailored treatment coupled with the recognition by industry participants of the co-development paradigm of drug diagnostics are the main factors driving the global diagnostic companion market.

Vancouver, BC -- (SBWire) -- 04/13/2021 --The global Companion Diagnostics Market is forecasted to reach USD 9.72 Billion by 2027, according to a new report by Emergen Research. Companion diagnostics are procedures or examinations that include knowledge necessary for the secure and prosperous usage of a medical drug in question. It enables the recognition of the possibility of an individual benefiting from a pharmaceutical drug or having adverse effects. It assists in assessing the patient reaction to a procedure so that medication may be modified to improve health and effectiveness. 

The latest report entails a comprehensive analysis of this particular business vertical while providing precise information related to the different industry segmentations. The report captures the essence of the market, offering details on its different valuations, present scenario, volume consumption, revenue share over the projected period. In addition, the report largely focuses on delivering information regarding the geographical outlook of the global Companion Diagnostics market, as well as the companies and organizations dominating the market.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/31

Further key findings from the report suggest

Based on technology, genetic sequencing generated a revenue of USD 0.47 billion in 2019. It projected to rise with a CAGR of 17.6% in the forecast period due to the highly technological sequencing methods that allow the detection of mutations, fusions, alterations in copy numbers, tumor mutation burden, microsatellite instability, etc.
The skin cancer disease indication expected to grow with a CAGR of 18.1% in the forecasted period attributable to the increasing skin cancer incidence due to medication side effects and prolonged sensitivity to toxic sun rays are helping doctors to manage patients with skin cancer.
The hospital application is the major contributor to the Companion Diagnostics Market. The hospital application of the North America region is the major shareholder of the market and held around 59.5% of the market in the year 2019, due to the availability of established hospital infrastructure, and qualified professionals increase the inclination of patients towards hospitals coupled with the growing patient pool due to a high incidence of chronic diseases would be helpful for the growth of the market.
Key participants include Agilent Technologies, Foundation Medicine, Myriad Genetic Laboratories, Thermo Fisher Scientific, Johnson & Johnson, Arup Laboratories, Abbott, MolecularMD, BioMérieux, and Illumina, among others.

Companion Diagnostics Market Segmentation:

For the purpose of this report, Emergen Research has segmented into the global Companion Diagnostics Market based on the technology, disease indication, application, and region:

Technology Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
Immunohistochemistry
In Situ Hybridization
Polymerase Chain Reaction
Genetic Sequencing

Disease Indication Outlook (Volume, Kilotons; 2017-2027, Revenue, USD Billion; 2017-2027)
Breast Cancer
Lung Cancer
Colorectal Cancer
Skin Cancer

Application Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
Hospitals
Diagnostic Laboratories

The research study also offers insights into various regulatory frameworks and evaluates the growth of the industry in each key region of the world. The report also provides an assessment of the micro and macro-economic factors influencing the growth of the market in the mentioned regions. The global Companion Diagnostics market is segmented into the following based on the key regions of the world:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/31

Key Factors influencing market remuneration:

The global Companion Diagnostics market report includes a detailed study of the product spectrum of the market and further describes the different product types, including One-sided, Two-sided, and Others.
The report zeroes in on the overall market dynamics and presents information with regard to the producers and distributors, manufacturing cost structure, and downstream buyers.
Details pertaining to the expected growth rate, industry share, revenue accumulated, and product segmentation are depicted in this report.
The application landscape of the global Companion Diagnostics market can be categorized into For Human, For Animals, and Others.
The study further examines the industry share and product demand of each application, coupled withthe predicted growth patterns of the various application segments.
Other vital factors, such as market concentration ratio and raw material processing rate, have also been covered under the latest study.

Table of Content

Chapter 1. Market Synopsis
    1.1. Market Definition
    1.2. Research Scope & Premise
    1.3. Methodology
    1.4. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Companion Diagnostics Market Segmentation & Impact Analysis
    4.1. Companion Diagnostics Market Product Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
                    4.2.2.1. Increasing drug diagnostic co-development
                    4.2.2.2. Improving regulatory scenario
                    4.2.2.3. Growing incidences of adverse drug reaction
          4.2.3. Market restraints analysis
                    4.2.3.1. High cost of companion diagnostics test in developing and underdeveloped regions
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. ETOP Analysis
    4.6. Porter's Five Forces Analysis
    4.7. Competitive Metric Space Analysis
    4.8. Price trend Analysis
    4.9. Customer Mapping
    4.10. Covid-19 Impact Analysis
    4.11. Global Recession Influence

Chapter 5. Companion Diagnostics Market By Technology Insights & Trends
    5.1. Technology Dynamics & Market Share, 2020 & 2027
    5.2. Immunohistochemistry
          5.2.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)
          5.2.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
    5.3. In Situ Hybridization
          5.3.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)
          5.3.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
    5.4. Polymerase Chain Reaction
          5.4.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)
          5.4.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)
    5.5. Genetic Sequencing
          5.5.1. Market estimates and forecast, 2017 – 2027 (USD Billion) (Kilotons)
          5.5.2. Market estimates and forecast, By Region, 2017 – 2027 (USD Billion) (Kilotons)

CONTINUED..!!

To read more about this report, visit @ https://www.emergenresearch.com/industry-report/companion-diagnostics-market

Thank you for reading our report. For further information, please connect with us to know more about the customization feature. Our team will work towards providing you a report well suited to your requirements.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release: https://www.emergenresearch.com/press-release/global-companion-diagnostics-market